Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Rabies
Varicella
2022
2021
Europe
Clear all
Type of publications
NITAG documentation
(102)
Systematic reviews (SYSVAC)
(10)
Topics
Available to download in languages
Regions
Europe
(112)
Africa
(40)
Americas
(104)
Eastern Mediterranean
(3)
South-East Asia
(3)
Western Pacific
(33)
Countries
Belgium
(20)
Denmark
(1)
France
(25)
Germany
(10)
Ireland
(11)
Italy
(1)
Netherlands
(8)
Spain
(3)
Sweden
(2)
Ukraine
(1)
United Kingdom
(25)
Diseases
COVID-19
(110)
Rabies
(1)
Varicella
(1)
Hepatitis B
(1)
Herpes zoster
(3)
Human papillomavirus (HPV)
(5)
Influenza
(9)
Meningococcal disease
(1)
Mpox // Monkeypox
(8)
Pertussis
(1)
Pneumococcal disease
(4)
Rotavirus
(3)
Vaccine topics
Acceptance
(5)
Coverage
(6)
Ethical issues
(5)
Target population
Adolescents
(2)
Adults
(3)
All age groups
(7)
Children
(2)
Healthcare workers
(3)
Newborn
(2)
Older adults
(2)
Parents/caregivers
(2)
Pregnant women
(2)
Risk group
(2)
Travellers
(1)
Publication date
2022
(35)
2021
(77)
2024
(2)
2023
(16)
2020
(18)
2019
(2)
2018
(3)
2017
(3)
2016
(2)
2013
(1)
2012
(2)
2010
(4)
2009
(2)
2005
(2)
112 results found
2021
∙
Haute Autorité de Santé
HAS recommendation on Vaccination strategy against Covid-19 - Place of the COMIRNATY® mRNA vaccine in 12-15 year olds - 3 June, 2021
2021
∙
Haute Autorité de Santé
HAS Sars-Cov-2 vaccination strategy - Role of socio-economic and professional factors in the risk of infection and severe forms of Covid-19 and updating of recommendations - 1 July 2021
2021
∙
Haut Conseil de la santé publique
HAS statement on AstraZeneca vaccine in response to new vaccine safety concerns - 8 April, 2021
2021
∙
Haut Conseil de la santé publique
HAS statement relating to the possibility of carrying out a vaccination schedule with two mRNA vaccines of different specialties in exceptional situations - 29 April, 2021
2021
∙
Haute Autorité de Santé
HAS vaccination strategy against Covid-19 - Place of the COMIRNATY® mRNA vaccine in 12-15 year olds - 03 June, 2021
2021
∙
JCVI
JCVI advice on the UK vaccine response to the Omicron variant
2021
∙
JCVI
JCVI advice on Third primary COVID-19 vaccine dose for people who are immunosuppressed - 1 September, 2021
2021
∙
JCVI
JCVI advice to mitigate impact of B1.617.2 variant - 14 May 2021
2021
∙
JCVI
JCVI advises on the use of the coronavirus (COVID-19) Oxford/AstraZeneca vaccine for people aged under 40 - 7 May 2021
2021
∙
JCVI
JCVI final statement on phase 2 of the COVID-19 vaccination programme: 13 April, 2021
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register